CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist
  • 190.09
  • +1.37+0.73%
Market Closed Nov 6 15:00 CST
76.23BMarket Cap20.06P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
1,101.74%4.98B
574.47%4.27B
689.82%5.83B
-59.79%403.96M
296.67%414.11M
582.91%632.76M
--737.61M
551.49%1B
--104.39M
-26.89%92.66M
Transactional financial assets
----
--1.63B
----
----
----
----
----
----
----
----
Notes receivable and accounts receivable
-35.36%81.16M
-59.87%85.8M
-43.00%119.89M
-52.24%118.13M
-28.30%125.56M
43.01%213.81M
--210.34M
93.06%247.34M
--175.12M
-2.35%149.51M
-Notes receivable
-8.51%11.7M
20.08%16.98M
24.31%24.6M
4.76%19.74M
-3.64%12.78M
6.43%14.14M
--19.79M
-17.86%18.84M
--13.27M
-49.86%13.29M
-Accounts receivable
-38.41%69.46M
-65.53%68.82M
-49.99%95.29M
-56.94%98.39M
-30.32%112.78M
46.58%199.67M
--190.55M
117.25%228.5M
--161.85M
7.60%136.22M
Other receivables (including interest and dividends)
546.04%23.72M
1,408.49%59.56M
204.17%10.14M
-23.97%3.9M
-5.47%3.67M
21.61%3.95M
--3.33M
74.06%5.14M
--3.88M
16.66%3.25M
-Accrued interest receivable
--14.35M
--48.59M
----
----
----
----
----
----
----
----
-Other receivable
----
178.05%10.98M
----
-23.97%3.9M
----
21.61%3.95M
----
74.06%5.14M
--3.88M
16.66%3.25M
Advance payment
83.56%92.31M
135.64%76.62M
131.16%62.94M
91.66%57.2M
101.15%50.29M
48.55%32.52M
--27.23M
30.23%29.84M
--25M
38.72%21.89M
Inventories
20.98%164.88M
15.96%154.18M
25.73%152.89M
39.06%140.91M
52.06%136.29M
44.92%132.96M
--121.6M
23.08%101.33M
--89.63M
16.73%91.75M
Receivable financing
37.31%12.34M
-58.08%6.75M
-28.25%6.32M
-4.22%19.71M
-15.70%8.99M
168.39%16.11M
--8.81M
201.31%20.58M
--10.66M
-20.07%6M
Other current assets
4,445.72%790.63M
254.52%94.56M
102.83%42.22M
84.20%32M
49.25%17.39M
168.23%26.67M
--20.82M
-34.31%17.37M
--11.65M
-47.74%9.94M
Total current assets
712.05%6.14B
502.40%6.38B
450.59%6.22B
-45.61%775.82M
79.92%756.3M
182.35%1.06B
--1.13B
236.55%1.43B
--420.34M
-13.51%374.99M
Non Current assets
Investment real estate
-15.07%1.41M
-14.52%1.47M
-14.01%1.53M
-13.54%1.59M
-13.10%1.65M
-12.68%1.72M
--1.78M
-11.93%1.84M
--1.9M
-11.25%1.97M
Fixed assets
----
52.04%495.48M
----
31.25%447.63M
----
-7.84%325.89M
----
-8.52%341.04M
--347.93M
22.32%353.61M
Constru in process
----
-75.30%26.02M
----
21.06%81.37M
----
87.40%105.34M
----
269.80%67.21M
--61.92M
-44.37%56.21M
Intangible assets
-5.03%26.94M
-5.20%27.26M
-5.20%27.63M
-5.19%28M
-5.20%28.37M
-5.22%28.75M
--29.14M
-5.23%29.53M
--29.93M
-5.20%30.33M
Development expenditure
----
----
----
----
--6.83M
----
----
----
----
----
Long deferred expense
46.19%3.8M
58.86%3.55M
-20.51%2.12M
1.38%1.82M
52.78%2.6M
44.88%2.24M
--2.67M
54.15%1.79M
--1.7M
1,884.56%1.54M
Deferred tax assets
109.43%222.08M
129.28%222.95M
-15.11%78.13M
-8.47%76.18M
30.00%106.04M
32.37%97.24M
--92.04M
26.49%83.23M
--81.57M
20.94%73.46M
Usufruct assets
207.71%22.81M
161.08%23.43M
-35.67%6.8M
-51.83%5.79M
-28.71%7.41M
-23.46%8.97M
--10.57M
-14.15%12.01M
--10.4M
19.23%11.73M
Other non current assets
-36.30%17.73M
-79.22%7.4M
-85.10%5.92M
-75.69%6.91M
6.10%27.84M
79.08%35.61M
--39.71M
26.67%28.43M
--26.24M
201.70%19.89M
Total non current assets
25.04%818.63M
33.31%807.56M
9.14%651.12M
14.90%649.28M
16.58%654.69M
10.39%605.77M
--596.62M
7.10%565.09M
--561.59M
9.40%548.74M
Total assets
393.28%6.96B
331.69%7.19B
298.02%6.87B
-28.44%1.43B
43.69%1.41B
80.20%1.66B
--1.73B
109.30%1.99B
--981.93M
-1.22%923.73M
Liabilities
Current liabilities
Short term loan
287.28%650.71M
276.74%670.73M
177.42%375.45M
77.34%275.12M
14.77%168.02M
-9.28%178.04M
--135.34M
-3.78%155.13M
--146.39M
39.00%196.25M
Notes payable and accounts payable
30.36%387.11M
24.41%362.79M
45.02%333.05M
71.99%339.07M
96.40%296.96M
156.02%291.6M
--229.65M
171.72%197.14M
--151.2M
121.25%113.9M
-Notes payable
82.89%104.56M
49.89%79.52M
-26.44%27.92M
159.90%31.17M
498.17%57.17M
267.09%53.05M
--37.95M
--11.99M
--9.56M
--14.45M
-Accounts payable
17.83%282.55M
18.75%283.27M
59.17%305.13M
66.30%307.9M
69.29%239.79M
139.88%238.55M
--191.7M
155.19%185.15M
--141.65M
93.18%99.44M
Contract liabilities
4,292.17%350.37M
7,442.54%357.92M
4,569.19%358.37M
-50.21%8.67M
58.67%7.98M
-9.29%4.75M
--7.68M
61.52%17.42M
--5.03M
-52.60%5.23M
Salaries payable
55.80%53.6M
31.74%38.06M
21.00%26.88M
10.74%44.29M
11.86%34.4M
20.40%28.89M
--22.22M
44.99%40M
--30.76M
27.34%24M
Taxs payable
6,964.44%222.88M
1,813.29%257.08M
657.28%76.24M
-47.94%17.87M
-84.19%3.15M
-16.25%13.44M
--10.07M
231.60%34.34M
--19.96M
43.32%16.04M
Other payable (including interest and dividends)
-0.05%121.59M
-0.01%143.89M
-16.76%117.65M
-23.59%136.64M
-15.14%121.65M
5.25%143.91M
--141.34M
26.60%178.82M
--143.36M
-31.20%136.73M
-Other payable
----
-0.01%143.89M
----
-23.59%136.64M
----
5.25%143.91M
----
26.60%178.82M
--143.36M
-25.03%136.73M
Non current liabilities due within one year
71.08%271.68M
238.40%305.16M
215.98%303.44M
122.07%220.5M
75.62%158.8M
38.48%90.18M
--96.03M
309.43%99.29M
--90.42M
1,979.92%65.12M
Other current liabilities
-18.10%10.4M
42.92%14.49M
61.22%24.76M
-22.61%11.66M
0.78%12.69M
-7.80%10.14M
--15.36M
-35.38%15.07M
--12.59M
-56.61%11M
Total current liabilities
157.37%2.07B
182.56%2.15B
145.69%1.62B
42.95%1.05B
34.01%803.65M
33.91%760.94M
--657.68M
56.41%737.2M
--599.71M
23.28%568.26M
Current liabilities
Long term account payable
----
----
----
-83.83%7.64M
----
-66.36%26.21M
----
11.23%47.22M
--53.29M
--77.92M
Estimate liabilities
-14.38%10.23M
-34.00%9.36M
-19.62%11.33M
-20.35%11.19M
-9.55%11.94M
5.00%14.18M
--14.1M
-11.12%14.05M
--13.21M
-34.34%13.5M
Deferred tax liabilities
----
----
----
----
--69.69K
--68.96K
----
--84.92K
----
----
Long term deferred income
-17.84%11.59M
-5.99%11.99M
16.49%15.23M
17.59%15.63M
11.42%14.11M
-0.80%12.75M
--13.07M
-57.19%13.29M
--12.66M
-66.35%12.85M
Lease liabilities
574.49%14.29M
528.52%15.75M
-14.24%3.41M
-82.24%1.02M
-58.47%2.12M
-60.12%2.51M
--3.98M
-36.20%5.72M
--5.1M
-5.37%6.28M
Total non current liabilities
240.45%649.93M
-31.15%206.99M
-67.24%99.88M
-31.51%219.39M
-34.22%190.9M
87.25%300.65M
--304.84M
116.03%320.33M
--290.23M
145.50%160.56M
Total liabilities
173.31%2.72B
122.04%2.36B
78.25%1.72B
20.40%1.27B
11.75%994.56M
45.66%1.06B
--962.52M
70.68%1.06B
--889.95M
38.46%728.82M
Shareholders equity
Paid-in capital
0.00%401M
0.00%401M
0.00%401M
0.00%401M
11.11%401M
11.11%401M
--401M
11.11%401M
--360.9M
0.00%360.9M
Capital reserve funds
1.07%867.76M
0.30%861.2M
0.02%858.69M
0.02%858.69M
5,935.84%858.6M
5,946.08%858.6M
--858.55M
5,960.23%858.55M
--14.22M
0.93%14.2M
Surplus reserve funds
0.00%13.54M
0.00%13.54M
0.00%13.54M
0.00%13.54M
0.00%13.54M
0.00%13.54M
--13.54M
0.00%13.54M
--13.54M
0.00%13.54M
Retained profit
443.36%2.94B
628.70%3.54B
863.21%3.88B
-228.23%-1.12B
-183.50%-857.09M
-239.89%-670.3M
---508.73M
-474.63%-341.98M
---302.32M
-1,260.50%-197.21M
Other composite income
4,245.48%16.72M
6,567.11%8.98M
37.78%-321.01K
-59.69%1.13M
-93.19%384.68K
-96.14%134.72K
---515.95K
1.24%2.79M
--5.64M
6.20%3.49M
Shareholders equity without minority interests
918.64%4.24B
700.80%4.83B
574.96%5.16B
-83.74%151.87M
352.71%416.43M
209.35%602.97M
--763.84M
181.42%933.89M
--91.99M
-52.32%194.91M
Total shareholder equity
918.64%4.24B
700.80%4.83B
574.96%5.16B
-83.74%151.87M
352.71%416.43M
209.35%602.97M
--763.84M
181.42%933.89M
--91.99M
-52.32%194.91M
Total liabilityies and equity
393.28%6.96B
331.69%7.19B
298.02%6.87B
-28.44%1.43B
43.69%1.41B
80.20%1.66B
--1.73B
109.30%1.99B
--981.93M
-1.22%923.73M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 1,101.74%4.98B574.47%4.27B689.82%5.83B-59.79%403.96M296.67%414.11M582.91%632.76M--737.61M551.49%1B--104.39M-26.89%92.66M
Transactional financial assets ------1.63B--------------------------------
Notes receivable and accounts receivable -35.36%81.16M-59.87%85.8M-43.00%119.89M-52.24%118.13M-28.30%125.56M43.01%213.81M--210.34M93.06%247.34M--175.12M-2.35%149.51M
-Notes receivable -8.51%11.7M20.08%16.98M24.31%24.6M4.76%19.74M-3.64%12.78M6.43%14.14M--19.79M-17.86%18.84M--13.27M-49.86%13.29M
-Accounts receivable -38.41%69.46M-65.53%68.82M-49.99%95.29M-56.94%98.39M-30.32%112.78M46.58%199.67M--190.55M117.25%228.5M--161.85M7.60%136.22M
Other receivables (including interest and dividends) 546.04%23.72M1,408.49%59.56M204.17%10.14M-23.97%3.9M-5.47%3.67M21.61%3.95M--3.33M74.06%5.14M--3.88M16.66%3.25M
-Accrued interest receivable --14.35M--48.59M--------------------------------
-Other receivable ----178.05%10.98M-----23.97%3.9M----21.61%3.95M----74.06%5.14M--3.88M16.66%3.25M
Advance payment 83.56%92.31M135.64%76.62M131.16%62.94M91.66%57.2M101.15%50.29M48.55%32.52M--27.23M30.23%29.84M--25M38.72%21.89M
Inventories 20.98%164.88M15.96%154.18M25.73%152.89M39.06%140.91M52.06%136.29M44.92%132.96M--121.6M23.08%101.33M--89.63M16.73%91.75M
Receivable financing 37.31%12.34M-58.08%6.75M-28.25%6.32M-4.22%19.71M-15.70%8.99M168.39%16.11M--8.81M201.31%20.58M--10.66M-20.07%6M
Other current assets 4,445.72%790.63M254.52%94.56M102.83%42.22M84.20%32M49.25%17.39M168.23%26.67M--20.82M-34.31%17.37M--11.65M-47.74%9.94M
Total current assets 712.05%6.14B502.40%6.38B450.59%6.22B-45.61%775.82M79.92%756.3M182.35%1.06B--1.13B236.55%1.43B--420.34M-13.51%374.99M
Non Current assets
Investment real estate -15.07%1.41M-14.52%1.47M-14.01%1.53M-13.54%1.59M-13.10%1.65M-12.68%1.72M--1.78M-11.93%1.84M--1.9M-11.25%1.97M
Fixed assets ----52.04%495.48M----31.25%447.63M-----7.84%325.89M-----8.52%341.04M--347.93M22.32%353.61M
Constru in process -----75.30%26.02M----21.06%81.37M----87.40%105.34M----269.80%67.21M--61.92M-44.37%56.21M
Intangible assets -5.03%26.94M-5.20%27.26M-5.20%27.63M-5.19%28M-5.20%28.37M-5.22%28.75M--29.14M-5.23%29.53M--29.93M-5.20%30.33M
Development expenditure ------------------6.83M--------------------
Long deferred expense 46.19%3.8M58.86%3.55M-20.51%2.12M1.38%1.82M52.78%2.6M44.88%2.24M--2.67M54.15%1.79M--1.7M1,884.56%1.54M
Deferred tax assets 109.43%222.08M129.28%222.95M-15.11%78.13M-8.47%76.18M30.00%106.04M32.37%97.24M--92.04M26.49%83.23M--81.57M20.94%73.46M
Usufruct assets 207.71%22.81M161.08%23.43M-35.67%6.8M-51.83%5.79M-28.71%7.41M-23.46%8.97M--10.57M-14.15%12.01M--10.4M19.23%11.73M
Other non current assets -36.30%17.73M-79.22%7.4M-85.10%5.92M-75.69%6.91M6.10%27.84M79.08%35.61M--39.71M26.67%28.43M--26.24M201.70%19.89M
Total non current assets 25.04%818.63M33.31%807.56M9.14%651.12M14.90%649.28M16.58%654.69M10.39%605.77M--596.62M7.10%565.09M--561.59M9.40%548.74M
Total assets 393.28%6.96B331.69%7.19B298.02%6.87B-28.44%1.43B43.69%1.41B80.20%1.66B--1.73B109.30%1.99B--981.93M-1.22%923.73M
Liabilities
Current liabilities
Short term loan 287.28%650.71M276.74%670.73M177.42%375.45M77.34%275.12M14.77%168.02M-9.28%178.04M--135.34M-3.78%155.13M--146.39M39.00%196.25M
Notes payable and accounts payable 30.36%387.11M24.41%362.79M45.02%333.05M71.99%339.07M96.40%296.96M156.02%291.6M--229.65M171.72%197.14M--151.2M121.25%113.9M
-Notes payable 82.89%104.56M49.89%79.52M-26.44%27.92M159.90%31.17M498.17%57.17M267.09%53.05M--37.95M--11.99M--9.56M--14.45M
-Accounts payable 17.83%282.55M18.75%283.27M59.17%305.13M66.30%307.9M69.29%239.79M139.88%238.55M--191.7M155.19%185.15M--141.65M93.18%99.44M
Contract liabilities 4,292.17%350.37M7,442.54%357.92M4,569.19%358.37M-50.21%8.67M58.67%7.98M-9.29%4.75M--7.68M61.52%17.42M--5.03M-52.60%5.23M
Salaries payable 55.80%53.6M31.74%38.06M21.00%26.88M10.74%44.29M11.86%34.4M20.40%28.89M--22.22M44.99%40M--30.76M27.34%24M
Taxs payable 6,964.44%222.88M1,813.29%257.08M657.28%76.24M-47.94%17.87M-84.19%3.15M-16.25%13.44M--10.07M231.60%34.34M--19.96M43.32%16.04M
Other payable (including interest and dividends) -0.05%121.59M-0.01%143.89M-16.76%117.65M-23.59%136.64M-15.14%121.65M5.25%143.91M--141.34M26.60%178.82M--143.36M-31.20%136.73M
-Other payable -----0.01%143.89M-----23.59%136.64M----5.25%143.91M----26.60%178.82M--143.36M-25.03%136.73M
Non current liabilities due within one year 71.08%271.68M238.40%305.16M215.98%303.44M122.07%220.5M75.62%158.8M38.48%90.18M--96.03M309.43%99.29M--90.42M1,979.92%65.12M
Other current liabilities -18.10%10.4M42.92%14.49M61.22%24.76M-22.61%11.66M0.78%12.69M-7.80%10.14M--15.36M-35.38%15.07M--12.59M-56.61%11M
Total current liabilities 157.37%2.07B182.56%2.15B145.69%1.62B42.95%1.05B34.01%803.65M33.91%760.94M--657.68M56.41%737.2M--599.71M23.28%568.26M
Current liabilities
Long term account payable -------------83.83%7.64M-----66.36%26.21M----11.23%47.22M--53.29M--77.92M
Estimate liabilities -14.38%10.23M-34.00%9.36M-19.62%11.33M-20.35%11.19M-9.55%11.94M5.00%14.18M--14.1M-11.12%14.05M--13.21M-34.34%13.5M
Deferred tax liabilities ------------------69.69K--68.96K------84.92K--------
Long term deferred income -17.84%11.59M-5.99%11.99M16.49%15.23M17.59%15.63M11.42%14.11M-0.80%12.75M--13.07M-57.19%13.29M--12.66M-66.35%12.85M
Lease liabilities 574.49%14.29M528.52%15.75M-14.24%3.41M-82.24%1.02M-58.47%2.12M-60.12%2.51M--3.98M-36.20%5.72M--5.1M-5.37%6.28M
Total non current liabilities 240.45%649.93M-31.15%206.99M-67.24%99.88M-31.51%219.39M-34.22%190.9M87.25%300.65M--304.84M116.03%320.33M--290.23M145.50%160.56M
Total liabilities 173.31%2.72B122.04%2.36B78.25%1.72B20.40%1.27B11.75%994.56M45.66%1.06B--962.52M70.68%1.06B--889.95M38.46%728.82M
Shareholders equity
Paid-in capital 0.00%401M0.00%401M0.00%401M0.00%401M11.11%401M11.11%401M--401M11.11%401M--360.9M0.00%360.9M
Capital reserve funds 1.07%867.76M0.30%861.2M0.02%858.69M0.02%858.69M5,935.84%858.6M5,946.08%858.6M--858.55M5,960.23%858.55M--14.22M0.93%14.2M
Surplus reserve funds 0.00%13.54M0.00%13.54M0.00%13.54M0.00%13.54M0.00%13.54M0.00%13.54M--13.54M0.00%13.54M--13.54M0.00%13.54M
Retained profit 443.36%2.94B628.70%3.54B863.21%3.88B-228.23%-1.12B-183.50%-857.09M-239.89%-670.3M---508.73M-474.63%-341.98M---302.32M-1,260.50%-197.21M
Other composite income 4,245.48%16.72M6,567.11%8.98M37.78%-321.01K-59.69%1.13M-93.19%384.68K-96.14%134.72K---515.95K1.24%2.79M--5.64M6.20%3.49M
Shareholders equity without minority interests 918.64%4.24B700.80%4.83B574.96%5.16B-83.74%151.87M352.71%416.43M209.35%602.97M--763.84M181.42%933.89M--91.99M-52.32%194.91M
Total shareholder equity 918.64%4.24B700.80%4.83B574.96%5.16B-83.74%151.87M352.71%416.43M209.35%602.97M--763.84M181.42%933.89M--91.99M-52.32%194.91M
Total liabilityies and equity 393.28%6.96B331.69%7.19B298.02%6.87B-28.44%1.43B43.69%1.41B80.20%1.66B--1.73B109.30%1.99B--981.93M-1.22%923.73M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data